Leading Element Driving Change in the Genome Editing/Genome Engineering Market in 2025: Rise In The Prevalence Of Cancer And Other Genetic Disorders Drives The Genome Editing Market Driver

How Are the key drivers contributing to the expansion of the genome editing/genome engineering market?
The increased occurrence of cancer and other genetic diseases is predicted to drive the expansion of the genome editing/genome engineering market. Cancer is a disease where a handful of the body's cells proliferate uncontrollably and invade other parts of the body. Genome engineering has the ability to swiftly modify immune cells and oncolytic viruses for cancer treatment applications. For example, in February 2022, the World Health Organization (WHO), a global health agency based in Switzerland, reported in an article that nearly 10 million deaths, roughly one in every six, were due to cancer, making it the main global cause of death. Furthermore, in June 2022, the Centers for Disease Control and Prevention (CDC), an American national public health organization, revealed in a report that in 2019, there were 1,752,735 new invasive cancer cases in total reported in the US, including 863,830 amongst women and 888,905 amongst men. The overall cancer incidence rate was 439 per 100,000 individuals. As a result, the escalating prevalence of cancer and other genetic diseases is fuelling the growth of the genome editing and genome engineering market.

Get Your Genome Editing/Genome Engineering Market Report Here:
https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

What growth opportunities are expected to drive the genome editing/genome engineering market's CAGR through 2034?
The market size for genome editing/genome engineering has seen a rapid increase in recent years. It is projected to expand from $8.62 billion in 2024 to $10.2 billion in 2025, with a compound annual growth rate (CAGR) of 18.2%. Factors contributing to this growth during the historic period include advancements in genetic and genomics research, a rise in genetic diseases, progress in gene therapy, investment in biotechnology and life sciences, potential uses in agriculture, and applications in model organisms.

In the upcoming years, the genome editing/genome engineering market is poised for a swift expansion, growing at a compound annual growth rate (CAGR) of 19.5% to reach a market size of $20.81 billion by 2029. This projected growth during the forecast period can be traced back to factors such as the introduction of prime editing, an emphasis on ethical and regulatory guidelines, its increasing use in drug discovery, potential for treating genetic disorders, customization for gene function studies, and a rising fascination towards epigenome editing. Key trends that are anticipated to shape the market during this period encompass developments in Crispr technology, burgeoning applications in therapeutics, introduction of novel genome editing tools, investments and partnerships, advanced delivery systems, as well as integration of artificial intelligence (AI) into genome editing design.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

What are the emerging trends shaping the future of the genome editing/genome engineering market?
Significant advancements in gene editing technology are becoming a prominent trend in the genome editing/genome engineering market. Leading companies in the market are focusing on developing novel tech solutions to enhance their market standing. For example, in May 2022, a team from Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a Spain-based evolutionary biology research institution, introduced an efficient and fast gene editing method for insects. The method, named Direct Parental CRISPR (DIPA-CRISPR), implies injecting substances into developing eggs in female adults instead of embryos. This innovative approach prevents the need to microinject CRISPR materials into insect embryos.

Which growth-oriented segments of the genome editing/genome engineering market are leading the industry's development?
The genome editing/genome engineering market covered in this report is segmented -

1) By Product And Service: Reagents And Consumables, Software And systems, Services
2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies
3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications
4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

Subsegments:
1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents
2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems
3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8010

What regions are leading the charge in the genome editing/genome engineering market?
North America was the largest region in the gene editing/genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the genome editing/genome engineering market?
Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

What Is Covered In The Genome Editing/Genome Engineering Global Market Report?

• Market Size Forecast: Examine the genome editing/genome engineering market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the genome editing/genome engineering market for a structured understanding.
• Key Players Overview: Analyze major players in the genome editing/genome engineering market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the genome editing/genome engineering market.
• Segment Contributions: Evaluate how different segments drive overall growth in the genome editing/genome engineering market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the genome editing/genome engineering market.
• Industry Challenges: Identify potential risks and obstacles affecting the genome editing/genome engineering market.
• Competitive Landscape: Review strategic developments in the genome editing/genome engineering market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.